GuruFocus.com
Champions Oncology Inc (CSBR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...
📊
AI Sentiment
Positive
6/10
- Home
- CSBR
as of 12-16-2025 1:22pm EST
$7.10
$0.85
-10.69%
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Chart Type:
Time Range:
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | BALTIMORE |
| Market Cap: | 90.0M | IPO Year: | 1986 |
| Target Price: | $12.00 | AVG Volume (30 days): | 9.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.21 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.61 - $11.99 | Next Earning Date: | 12-15-2025 |
| Revenue: | $56,878,000 | Revenue Growth: | 10.11% |
| Revenue Growth (this year): | 7.31% | Revenue Growth (next year): | 12.01% |
AI-Powered CSBR Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 69.66%
69.66%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Champions Oncology Inc. News
CSBR Breaking Stock News: Dive into CSBR Ticker-Specific Updates for Smart Investing
MT Newswires
Champions Oncology Q2 Non-GAAP Earnings Fall, Revenue Rises
âž–
AI Sentiment
Neutral
5/10
ACCESS Newswire
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
📊
AI Sentiment
Positive
7/10
Compare CSBR vs Leading Stocks
See how CSBR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CSBR Champions Oncology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.